logo

For the Inventor, By the Inventor

Taipei, Taiwan

Alar Pharmaceuticals, Inc.


USPTO Granted Patents = 4


Forward Citations = 0

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Tong-Ho Lin (4 out of 5 patents)

silverMedal Yung-Shun Wen (4 out of 4 patents)

bronzeMedal Jui-Wei Liang (2 out of 2 patents)

4.  Wei-Ju Chang (1 out of 1 patent)

5.  Chia-Hsien Chen (1 out of 1 patent)

6.  Zhi-Rong Wu (1 out of 1 patent)

7.  Ying-Ting Liu (1 out of 1 patent)

8.  Rui-Zhi Hou (0 patent)

9.  Chia-Hsien Chen (0 patent)

10.  Yung-Shun Wen (0 patent)

11.  Tong-Ho Lin (0 patent)

12.  Chia-Hsien Chen (0 patent)

13.  Wei-Ju Chang (0 patent)


4 patents:

1. 12201630 - Naltrexone injectable sustained release formulation (2025-01-21),
2. 11981617 - Ketamine pamoate and use thereof (2024-05-14),
3. 11524965 - Long-acting injectable formulations and crystalline forms of buprenorphine derivatives (2022-12-13),
4. 10744132 - Sustained-release buprenorphine formulations (2020-08-18),
logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#911 in Taipei

#2,620 in Taiwan

...
Taipei, Taiwan

Alar Pharmaceuticals, Inc.

Forward Citations = 0

7 inventors:

goldMedal Tong-Ho Lin (4 out of 5 patents)

silverMedal Yung-Shun Wen (4 out of 4 patents)

bronzeMedal Jui-Wei Liang (2 out of 2 patents)

4.  Wei-Ju Chang (1 out of 1 patent)

5.  Chia-Hsien Chen (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com
Loading…